<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Induction agents for rapid sequence intubation in adults for emergency medicine and critical care
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Induction agents for rapid sequence intubation in adults for emergency medicine and critical care
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Induction agents for rapid sequence intubation in adults for emergency medicine and critical care
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            David Caro, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Ron M Walls, MD, FRCPC, FAAEM
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jonathan Grayzel, MD, FAAEM
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Feb 24, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The first task of any clinician managing an acutely unstable patient is to secure the airway. In most circumstances, emergency clinicians use rapid sequence intubation (RSI) to accomplish this task. RSI incorporates a rapidly acting sedative (ie, induction) agent, in addition to a neuromuscular blocking (ie, paralytic) agent, to create optimal intubating conditions. Selection of the sedative agent and dose most appropriate for the clinical scenario is an important component of RSI.
        </p>
        <p>
         The pharmacology and selection of induction agents for use in emergency RSI outside of the operating theater will be reviewed here. The techniques and other medications used in the performance of RSI, as well as other aspects of airway management, are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/270.html" rel="external">
          "Rapid sequence intubation in adults for emergency medicine and critical care"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6390.html" rel="external">
          "Rapid sequence intubation (RSI) in children for emergency medicine: Approach"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/279.html" rel="external">
          "Neuromuscular blocking agents (NMBAs) for rapid sequence intubation in adults for emergency medicine and critical care"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/282.html" rel="external">
          "Pretreatment medications for rapid sequence intubation in adults for emergency medicine and critical care"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          RAPID SEQUENCE INTUBATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Rapid sequence intubation (RSI) is the standard of care in emergency airway management for intubations not anticipated to be difficult [
         <a href="#rid1">
          1-4
         </a>
         ]. RSI is the virtually simultaneous administration of a sedative and a neuromuscular blocking agent to render a patient rapidly unconscious and flaccid in order to facilitate emergency endotracheal intubation and to minimize the risk of aspiration. Multiple studies confirm the high-success rate of RSI using the combination of a sedative and a paralytic drug [
         <a href="#rid2">
          2-4
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/270.html" rel="external">
          "Rapid sequence intubation in adults for emergency medicine and critical care"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/279.html" rel="external">
          "Neuromuscular blocking agents (NMBAs) for rapid sequence intubation in adults for emergency medicine and critical care"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6390.html" rel="external">
          "Rapid sequence intubation (RSI) in children for emergency medicine: Approach"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          INDUCTION AGENTS
         </span>
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Overview
         </span>
         <span class="headingEndMark">
          —
         </span>
         Induction agents (sedatives) are integral to the performance of rapid sequence intubation (RSI) [
         <a href="#rid5">
          5
         </a>
         ]. They provide amnesia, blunt sympathetic responses, and can improve intubating conditions.
        </p>
        <p>
         When a paralytic agent is used for intubation without sedation, the patient may be fully aware of his or her environment, including pain, but unable to respond [
         <a href="#rid6">
          6-9
         </a>
         ]. In addition to its inhumanity, this circumstance allows for potentially adverse physiologic responses to airway manipulation, including tachycardia, hypertension, and elevated intracranial pressure (ICP) [
         <a href="#rid10">
          10
         </a>
         ]. Sedative use prevents or minimizes these effects. Furthermore, clinicians can sometimes select an induction agent that both facilitates RSI and ameliorates the patient's underlying condition. As an example,
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          ketamine
         </a>
         can be used in severe asthma to reduce bronchospasm [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p>
         Use of sedatives may also improve the laryngoscopic view obtained during RSI [
         <a href="#rid5">
          5,12,13
         </a>
         ]. During RSI, the clinician must perform laryngoscopy during the earliest phase of neuromuscular paralysis. Sedatives improve laryngoscopy in part by supplementing the yet incomplete relaxation provided by the paralytic. Even in the presence of a full neuromuscular blocking dose of a paralytic, the addition of a sedative improves intubating conditions during RSI [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
         Each of the major induction agents in common use is discussed below (
         <a class="graphic graphic_table graphicRef64272" href="/z/d/graphic/64272.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Etomidate
         </span>
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h3">
          General use
         </span>
         <span class="headingEndMark">
          —
         </span>
         <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">
          Etomidate
         </a>
         is an imidazole-derived, sedative-hypnotic agent that is frequently used for RSI. Etomidate acts directly on the gamma amino butyric acid (GABA) receptor complex, blocking neuroexcitation and producing anesthesia. For RSI, etomidate is given by intravenous (IV) push in a dose of 0.3 mg/kg, with a time to effect of 15 to 45 seconds and a duration of action of 3 to 12 minutes [
         <a href="#rid14">
          14
         </a>
         ]. It is the most hemodynamically neutral of the sedative agents used for RSI, and does not stimulate histamine release [
         <a href="#rid15">
          15-21
         </a>
         ].
        </p>
        <p>
         <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">
          Etomidate
         </a>
         provides no analgesic effect, so it does not blunt the noxious stimulation of the upper airway during laryngoscopy and intubation. For patients in whom this is a concern (eg, patients with cardiovascular disease or elevated intracranial pressure), an opioid analgesic, such as
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         , is often given during the pretreatment phase of RSI [
         <a href="#rid22">
          22
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/282.html" rel="external">
          "Pretreatment medications for rapid sequence intubation in adults for emergency medicine and critical care"
         </a>
         .)
        </p>
        <p>
         The hemodynamic stability associated with
         <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">
          etomidate
         </a>
         makes it a particularly useful medication for the intubation of hypotensive patients, as well as for patients with intracranial pathology, when hypotension must be avoided [
         <a href="#rid15">
          15-19,21
         </a>
         ]. Etomidate causes a mild increase in airway resistance, but may be used in patients with bronchospasm [
         <a href="#rid23">
          23
         </a>
         ].
        </p>
        <p>
         Concerns with
         <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">
          etomidate
         </a>
         include adrenal suppression, myoclonus, and evidence of regional cerebral excitation (determined by electroencephalogram) after intubation [
         <a href="#rid18">
          18,24,25
         </a>
         ]. Myoclonus has been misidentified as seizure activity, leading to incorrect recommendations that etomidate be avoided in patients with seizure disorders. Myoclonus during RSI is brief and minimal, because of the concomitant administration of a paralytic agent, and of no clinical significance. Etomidate decreases cerebral blood flow and cerebral metabolic oxygen demand, while preserving cerebral perfusion pressure [
         <a href="#rid21">
          21
         </a>
         ]. Postintubation sedation with
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         or a benzodiazepine helps to prevent neuroexcitation.
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h3">
          Adrenocortical suppression
         </span>
         <span class="headingEndMark">
          —
         </span>
         The major controversy surrounding
         <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">
          etomidate
         </a>
         stems from the reversible adrenocortical suppression associated with its use. The evidence surrounding this issue is reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/94533.html" rel="external">
          "General anesthesia: Intravenous induction agents", section on 'Etomidate'
         </a>
         .)
        </p>
        <p>
         <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">
          Etomidate
         </a>
         is a reversible inhibitor of 11-beta-hydroxylase, which converts 11-deoxycortisol to cortisol (
         <a class="graphic graphic_figure graphicRef71558" href="/z/d/graphic/71558.html" rel="external">
          figure 1
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/120.html" rel="external">
          "Adrenal steroid biosynthesis"
         </a>
         .) A single dose of etomidate causes a transient but measurable decrease in the level of circulating cortisol that occurs in response to the administration of exogenous ACTH, although cortisol levels do not fall below the normal physiologic range. This effect does not persist beyond 12 to 24 hours.
        </p>
        <p>
         We recognize the critical importance of maintaining adequate blood pressure early in the treatment of sepsis and, pending more definitive studies, we believe that
         <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">
          etomidate
         </a>
         is an acceptable induction agent for patients with severe sepsis. Etomidate has the advantages of hemodynamic stability when compared with most other sedative or induction agents, and familiarity because of its widespread use for RSI outside the operating room. When intubating the critically ill patient with possible adrenal insufficiency, the clinician must weigh the theoretical risk of cortisol suppression against the hemodynamic instability that may be caused by alternative induction agents.
        </p>
        <p>
         <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">
          Etomidate
         </a>
         should
         <strong>
          NOT
         </strong>
         be used as an infusion or in repeated bolus doses for maintenance of sedation after intubation. Emergency clinicians should inform the physicians assuming care for the patient in the intensive care unit or operating suite if etomidate has been used for induction. If ACTH stimulation testing is being considered, clinicians should be aware that the results may be affected by prior administration of etomidate. (See
         <a class="medical medical_review" href="/z/d/html/1613.html" rel="external">
          "Evaluation and management of suspected sepsis and septic shock in adults"
         </a>
         .)
        </p>
        <p>
         Some authors recommend the use of empiric glucocorticoids for the first 24 hours after a dose of
         <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">
          etomidate
         </a>
         in patients with sepsis, but this approach lacks support from outcome studies [
         <a href="#rid26">
          26,27
         </a>
         ]. We suggest that patients with sepsis who receive etomidate for RSI also receive a single dose of glucocorticoid (eg,
         <a class="drug drug_general" data-topicid="8535" href="/z/d/drug information/8535.html" rel="external">
          hydrocortisone
         </a>
         100 mg IV)
         <strong>
          only
         </strong>
         if they manifest hypotension that is refractory to treatment with aggressive fluid resuscitation and a vasopressor. This approach is consistent with that used for patients who do not receive etomidate. A discussion of the role of glucocorticoids in septic shock is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1654.html" rel="external">
          "Glucocorticoid therapy in septic shock in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Benzodiazepines
         </span>
         <span class="headingEndMark">
          —
         </span>
         Benzodiazepines cause sedation and amnesia through their effects on the gamma amino butyric acid (GABA) receptor complex.
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          Midazolam
         </a>
         is the most rapidly acting benzodiazepine commonly used for RSI [
         <a href="#rid28">
          28,29
         </a>
         ]. The induction dose for midazolam is 0.1 to 0.3 mg/kg IV push, with a time to effect of approximately 30 to 60 seconds, and a duration of action of 15 to 30 minutes [
         <a href="#rid28">
          28,29
         </a>
         ].
        </p>
        <p>
         Like all benzodiazepines,
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          midazolam
         </a>
         does not provide analgesia but does possess antiseizure effects, making it an effective agent for RSI in patients with status epilepticus.
        </p>
        <p>
         The routine induction dose of
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          midazolam
         </a>
         for RSI is 0.2 mg/kg. In this dose, midazolam causes moderate hypotension, with an average drop in mean arterial blood pressure in healthy patients of 10 to 25 percent [
         <a href="#rid28">
          28,29
         </a>
         ]. This tendency to induce hypotension limits midazolam's usefulness in the setting of hypovolemia or shock. If midazolam must be used in such patients, we suggest a dose of 0.1 mg/kg, which will somewhat delay the speed of onset and decrease the depth of sedation achieved, but should not severely compromise intubating conditions. For patients in shock, we suggest
         <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">
          etomidate
         </a>
         or
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          ketamine
         </a>
         because of their superior hemodynamic profiles. (See
         <a class="local">
          'Etomidate'
         </a>
         above and
         <a class="local">
          'Ketamine'
         </a>
         below.)
        </p>
        <p>
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          Midazolam
         </a>
         is frequently underdosed (common dose 0.05 mg/kg) when used for emergency department RSI [
         <a href="#rid30">
          30
         </a>
         ]. Midazolam is often used for procedural sedation in much smaller doses than are required for RSI, which may contribute to underdosing [
         <a href="#rid29">
          29
         </a>
         ].
        </p>
        <p>
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          Midazolam
         </a>
         can be used as an infusion for long-term sedation. Doses of 0.05 to 0.4 mg/kg per hour IV have been shown to be safe and effective in critically ill neonates and children [
         <a href="#rid31">
          31,32
         </a>
         ], including neonates undergoing extracorporeal membrane oxygenation [
         <a href="#rid33">
          33
         </a>
         ]. Dosing in intubated adults should be titrated to an endpoint of adequate sedation, preferably using a sedation scale.
        </p>
        <p>
         <a class="drug drug_general" data-topicid="9573" href="/z/d/drug information/9573.html" rel="external">
          Lorazepam
         </a>
         and
         <a class="drug drug_general" data-topicid="9345" href="/z/d/drug information/9345.html" rel="external">
          diazepam
         </a>
         are benzodiazepines used frequently for long-term sedation following intubation, but are not recommended for RSI. Both require propylene glycol as a diluent, and there are reports of propylene glycol toxicity associated with long-term infusions [
         <a href="#rid34">
          34
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1616.html" rel="external">
          "Sedative-analgesia in ventilated adults: Medication properties, dose regimens, and adverse effects", section on 'Benzodiazepines'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Ketamine
         </span>
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h3">
          General use
         </span>
         <span class="headingEndMark">
          —
         </span>
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          Ketamine
         </a>
         is a dissociative anesthetic agent, structurally similar to phencyclidine (PCP). It is unique among sedative agents in that it provides analgesia along with its amnestic and sedative effects. Ketamine is given IV in doses of 1 to 2 mg/kg, with a time to effect of 45 to 60 seconds, and a duration of action of 10 to 20 minutes.
        </p>
        <p>
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          Ketamine
         </a>
         acts at many receptors causing a range of effects. It is thought to act as an antagonist of the N-methyl-D-aspartate receptor at the GABA receptor complex, causing neuro-inhibition and anesthesia. It excites opioid receptors within the insular cortex, putamen, and thalamus, producing analgesia [
         <a href="#rid35">
          35,36
         </a>
         ]. It stimulates catecholamine receptors and release of catecholamines leading to increases in heart rate, contractility, mean arterial pressure, and cerebral blood flow [
         <a href="#rid35">
          35,37-39
         </a>
         ]. Ketamine decreases the production of vascular nitric oxide, diminishing its vasodilatory effect [
         <a href="#rid40">
          40
         </a>
         ], and inhibits nicotinic acetylcholine receptors [
         <a href="#rid41">
          41
         </a>
         ].
        </p>
        <p>
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          Ketamine
         </a>
         preserves respiratory drive and has both a rapid onset of action and analgesic properties. This makes it a good choice for "awake" intubation attempts, when laryngoscopy is performed on a patient who is moderately sedated and topically anesthetized but not paralyzed due to concerns about a difficult airway. (See
         <a class="local">
          'Conditions precluding use of a paralytic'
         </a>
         below.)
        </p>
        <p>
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          Ketamine
         </a>
         causes sympathetic stimulation and is among the most hemodynamically stable of the available sedative induction agents, making it an attractive choice for hypotensive patients requiring RSI [
         <a href="#rid37">
          37,38
         </a>
         ]. However, observational evidence and clinical experience suggest that patients who are depleted of catecholamines due to their underlying disease or otherwise have a blunted sympathetic response may develop hypotension following administration of ketamine for RSI [
         <a href="#rid42">
          42
         </a>
         ]. In a multi-center, observational study of ED patients requiring RSI for both medical and traumatic indications, 18.3 percent of patients sedated with ketamine (n = 738) sustained peri-intubation hypotension compared with 12.4 percent of those sedated with
         <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">
          etomidate
         </a>
         (n = 6068) (effect size difference 5.9 percent; 95% CI 2.9-8.8) [
         <a href="#rid43">
          43
         </a>
         ]. A study using the same airway registry database but limited to ED patients intubated for sepsis reported a higher rate of post-intubation hypotension among patients sedated with ketamine (n = 140) compared with etomidate (n = 363), 74 and 50 percent, respectively (OR 2.9; 95% CI 1.9-4.5) [
         <a href="#rid44">
          44
         </a>
         ].
        </p>
        <p>
         Theoretically, ketamine-induced catecholamine release causes bronchodilation. Limited evidence from animal studies suggests the drug may also have direct bronchodilatory effects. Although definitive evidence is lacking, many clinicians use
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          ketamine
         </a>
         as an induction agent in severe asthmatics needing RSI. Use of ketamine infusions in subanesthetic doses during asthma exacerbations provides no additional benefit compared with standard therapy [
         <a href="#rid39">
          39
         </a>
         ]. Case reports suggest larger doses may be needed [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p>
         When considering whether to use
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          ketamine
         </a>
         for induction in patients with coronary disease, clinicians must weigh ketamine's potential cardiovascular benefits against its potential to induce cardiac ischemia through sympathetic stimulation. Ketamine appears to have beneficial effects on stunned myocardium in vitro [
         <a href="#rid38">
          38
         </a>
         ]. When used prior to myocardial oxygen deprivation, ketamine resulted in better recovery after reperfusion. Contractility may also improve with ketamine use [
         <a href="#rid37">
          37
         </a>
         ].
        </p>
        <p>
         The emergence phenomenon, in which patients experience disturbing dreams as they emerge from ketamine-induced anesthesia, limits use of the drug for procedural sedation or elective anesthesia in adult patients. Reemergence phenomena are of less concern when
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          ketamine
         </a>
         is used for RSI, after which the patient is generally sedated with benzodiazepines for a substantial period. One study found that while dreams occurred frequently following sedative doses of ketamine, they were generally pleasant, and the frequency of reemergence phenomena and delirium was markedly reduced by concomitant use of a benzodiazepine [
         <a href="#rid45">
          45
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h3">
          Elevated intracranial pressure
         </span>
         <span class="headingEndMark">
          —
         </span>
         Controversy persists regarding whether
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          ketamine
         </a>
         elevates intracranial pressure (ICP) in patients with head injury [
         <a href="#rid46">
          46
         </a>
         ]. Opponents emphasize that ketamine-induced sympathetic stimulation causes ICP elevation, potentially exacerbating the condition of such patients [
         <a href="#rid47">
          47,48
         </a>
         ]. However, when ketamine is used with a GABA agonist, this rise in ICP may not occur [
         <a href="#rid49">
          49,50
         </a>
         ]. Furthermore, by increasing cerebral perfusion, ketamine may benefit patients with a neurologic injury [
         <a href="#rid35">
          35,49
         </a>
         ].
        </p>
        <p>
         On balance, evidence suggesting
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          ketamine
         </a>
         elevates ICP is weak, and evidence that harm might ensue is weaker. We believe ketamine is a reasonable alternative induction agent to
         <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">
          etomidate
         </a>
         for RSI in patients with suspected ICP elevation and normal or low blood pressure [
         <a href="#rid51">
          51-53
         </a>
         ]. In patients with hypertension and suspected ICP elevation, ketamine should be avoided because of its tendency to further elevate blood pressure.
        </p>
        <p>
         The best available evidence about this issue comes from a systematic review of 10 trials involving 953 critically ill patients, all managed with intubation and mechanical ventilation, which concluded that the use of IV
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          ketamine
         </a>
         did not adversely affect patient outcomes, including mortality and neurologic outcome [
         <a href="#rid54">
          54
         </a>
         ]. Although most trials included in the review had methodological limitations, two randomized, double-blinded trials comparing the effects of prolonged ketamine and
         <a class="drug drug_general" data-topicid="9954" href="/z/d/drug information/9954.html" rel="external">
          sufentanil
         </a>
         infusions found no difference in the mean daily intracranial pressure and cerebral perfusion pressure of patients, all of whom had sustained traumatic brain injury.
        </p>
        <p>
         Other studies suggest
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          ketamine
         </a>
         does not interfere with cerebral metabolism; it does not increase cerebral oxygen consumption and does not reduce regional glucose metabolism [
         <a href="#rid35">
          35,55,56
         </a>
         ]. Ketamine may also offset decrease in mean arterial pressure caused by
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         , a drug commonly used as part of RSI in patients with a head injury [
         <a href="#rid57">
          57
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h2">
          Propofol
         </span>
         <span class="headingEndMark">
          —
         </span>
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          Propofol
         </a>
         is a highly lipid-soluble, alkylphenol derivative that acts at the GABA receptor causing sedation and amnesia. Sedation occurs through direct suppression of brain activity, while amnesia appears to result from interference with long-term memory creation [
         <a href="#rid58">
          58,59
         </a>
         ]. Induction doses of 1.5 to 3 mg/kg IV can be used, with a time to effect of approximately 15 to 45 seconds, and a duration of action of 5 to 10 minutes. Propofol does not provide analgesia. In addition to its use for RSI, propofol is used for long-term sedation in critically ill patients, sedation for brief procedures, and induction of anesthesia, all of which are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1616.html" rel="external">
          "Sedative-analgesia in ventilated adults: Medication properties, dose regimens, and adverse effects", section on 'Propofol'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/94533.html" rel="external">
          "General anesthesia: Intravenous induction agents", section on 'Propofol'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/139217.html" rel="external">
          "Procedural sedation in adults in the emergency department: Medication selection, dosing, and discharge criteria", section on 'Propofol'
         </a>
         .)
        </p>
        <p>
         The pharmacokinetic properties of
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         do not appear to differ among races or between genders [
         <a href="#rid60">
          60,61
         </a>
         ], but children appear to have a slightly longer time to peak serum concentration [
         <a href="#rid62">
          62
         </a>
         ].
        </p>
        <p>
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          Propofol
         </a>
         reduces airway resistance and can be a useful induction agent for patients with bronchospasm undergoing RSI [
         <a href="#rid23">
          23,63,64
         </a>
         ]. Its neuroinhibitory effects make propofol a good induction agent for patients with intracranial pathology, provided they are hemodynamically stable. Propofol suppresses sympathetic activity, causing myocardial depression and peripheral vasodilation [
         <a href="#rid65">
          65-68
         </a>
         ]. A decrease in mean arterial pressure (MAP) caused by propofol can reduce cerebral perfusion pressure, thereby exacerbating a neurologic injury [
         <a href="#rid69">
          69
         </a>
         ]. The usual decrease in MAP is approximately 10 mmHg [
         <a href="#rid70">
          70
         </a>
         ].
        </p>
        <p>
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          Propofol
         </a>
         does not prolong the QT interval, unlike some other anesthetic agents [
         <a href="#rid71">
          71,72
         </a>
         ]. Serum triglycerides and serum lipase rise during propofol infusions [
         <a href="#rid73">
          73
         </a>
         ]. Although the manufacturer lists egg or soybean allergies as contraindications to the use of propofol, significant allergic reactions to the newer preparation of the drug appear to be rare. (See
         <a class="medical medical_review" href="/z/d/html/2077.html" rel="external">
          "Perioperative anaphylaxis: Clinical manifestations, etiology, and management", section on 'Hypnotic induction agents'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3259775661">
         <span class="h2">
          Ketamine and propofol combination (ketofol)
         </span>
         <span class="headingEndMark">
          —
         </span>
         The combination of
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          ketamine
         </a>
         and
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         (“ketofol”) was developed for procedural sedation and is used by some clinicians for induction during RSI. The purported benefit of this combination is to obtain the benefits of each drug (eg, analgesic effects of ketamine), while minimizing the potential harms (eg, hypotensive effects of propofol). In addition, as both medications are potent bronchodilators, the combination may be ideal for patients with bronchospasm. Ketofol is discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/139217.html" rel="external">
          "Procedural sedation in adults in the emergency department: Medication selection, dosing, and discharge criteria", section on 'Premixed with propofol (ketofol)'
         </a>
         .)
        </p>
        <p>
         Few, small studies address the efficacy of ketofol for RSI [
         <a href="#rid74">
          74-78
         </a>
         ]. While sedation is reported to be adequate, ketofol does appear to cause a small decline in mean arterial pressure (approximately 2 to 6 mmHg in most studies) when used for RSI, although such declines are comparable to or less than those caused by
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         alone. As dosing varies among studies, it is difficult to determine the best approach to dosing. Further study is needed before ketofol can be recommended for widespread use with RSI.
        </p>
        <p class="headingAnchor" id="H3717908798">
         <span class="h2">
          Barbiturates
         </span>
         <span class="headingEndMark">
          —
         </span>
         Barbiturates are no longer readily available nor widely used as induction agents for intubation. For those with access to these medications, a brief overview of their use is provided here. There is no indication for the use of a barbiturate induction agent instead of
         <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">
          etomidate
         </a>
         ,
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         , or
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          ketamine
         </a>
         when these agents are available.
        </p>
        <p>
         The ultrashort-acting barbiturates interact with the barbiturate component of the GABA receptor complex, causing profound amnesia and sedation. Thiopental sodium was the barbiturate most commonly used for RSI. The induction dose is 3 to 5 mg/kg IV, with a time to effect of less than 30 seconds, and a duration of action of 5 to 10 minutes [
         <a href="#rid79">
          79
         </a>
         ].
         <a class="drug drug_general" data-topicid="9629" href="/z/d/drug information/9629.html" rel="external">
          Methohexital
         </a>
         is another barbiturate used for induction; its induction dose is 1 to 3 mg/kg IV, with a time to effect of less than 30 seconds, and a duration of action of approximately 5 to 10 minutes. Barbiturates do not provide analgesia.
        </p>
        <p>
         Thiopental suppresses neuronal activity, making it a useful induction agent in hemodynamically stable patients with conditions that can elevate intracranial pressure (ICP), including seizures, intracranial bleeding, or trauma. However, thiopental is a venodilator with negative cardiac inotropic effects, and can induce profound hypotension in the doses used for induction of anesthesia. Clinicians must exercise great care when using it in hemodynamically unstable patients or patients prone to hypotension, such as the elderly. For emergency RSI, a dose of 3 mg/kg is used; a reduced dose of 2 or 1 mg/kg is used in the setting of hemodynamic compromise [
         <a href="#rid80">
          80
         </a>
         ]. Reductions in ICP associated with thiopental may be caused in part by a decrease in mean arterial pressure, which decreases cerebral perfusion.
        </p>
        <p>
         Thiopental causes histamine release and can induce or exacerbate bronchospasm [
         <a href="#rid81">
          81
         </a>
         ]. Therefore, thiopental should not be used in patients with reactive airway disease. Thiopental and
         <a class="drug drug_general" data-topicid="9629" href="/z/d/drug information/9629.html" rel="external">
          methohexital
         </a>
         suppress white blood cell recruitment, activation, and activity, both in vitro [
         <a href="#rid82">
          82,83
         </a>
         ] and in vivo [
         <a href="#rid84">
          84-86
         </a>
         ]. This effect has been attributed to a number of causes, including suppression of nuclear transcription factor [
         <a href="#rid87">
          87
         </a>
         ], an increase in apoptosis [
         <a href="#rid82">
          82
         </a>
         ], and a decrease in phagocytosis [
         <a href="#rid83">
          83
         </a>
         ]. These immunosuppressive effects make barbiturates poor induction agents in the setting of sepsis.
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h1">
          CHOICE OF INDUCTION AGENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Certain induction agents may offer advantages over others in specific clinical scenarios.
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h2">
          Head injury or stroke
         </span>
         <span class="headingEndMark">
          —
         </span>
         In the patient with potentially elevated intracranial pressure (ICP) from head injury or stroke or other conditions, adequate cerebral perfusion pressure must be maintained to prevent secondary brain injury. This means avoiding significant elevations in ICP and maintaining adequate mean arterial pressure [
         <a href="#rid80">
          80
         </a>
         ]. For these reasons, we suggest
         <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">
          etomidate
         </a>
         for induction of these patients [
         <a href="#rid20">
          20
         </a>
         ].
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          Ketamine
         </a>
         is a reasonable alternative. If signs of cerebral herniation are present prior to intubation, we suggest using etomidate and avoiding ketamine [
         <a href="#rid52">
          52
         </a>
         ]. (See
         <a class="local">
          'Etomidate'
         </a>
         above and
         <a class="local">
          'Ketamine'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/4826.html" rel="external">
          "Management of acute moderate and severe traumatic brain injury"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1126.html" rel="external">
          "Initial assessment and management of acute stroke"
         </a>
         .)
        </p>
        <p>
         If significant hypertension (mean arterial blood pressure &gt;120 mmHg) is present at the time of induction,
         <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">
          etomidate
         </a>
         is strongly preferable to
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          ketamine
         </a>
         , as it will not further elevate the blood pressure. In normotensive or hypotensive patients, we favor etomidate, although either agent can be used. In the severely hypotensive patient, a reduced dose (25 to 50 percent less than standard) of either etomidate or ketamine may be used.
        </p>
        <p>
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          Midazolam
         </a>
         and
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         have been used in head-injured patients, but we do not recommend midazolam as an induction agent in general. In hemodynamically unstable, head-injured patients, both agents should be avoided because of the risk of hypotension-induced brain injury [
         <a href="#rid5">
          5,20,69,85,88-90
         </a>
         ]. If no alternative agents are available, the induction dose of midazolam or propofol should be reduced by 50 percent to minimize risk of exacerbating hypotension, and hence, brain injury.
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h2">
          Status epilepticus
         </span>
         <span class="headingEndMark">
          —
         </span>
         Few studies of RSI for status epilepticus have been performed. Based on limited evidence, we suggest
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         or
         <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">
          etomidate
         </a>
         be used for the induction of RSI in patients with status epilepticus.
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          Midazolam
         </a>
         may be used, but its slower onset and propensity for hypotension make it less desirable. (See
         <a class="medical medical_review" href="/z/d/html/96933.html" rel="external">
          "Convulsive status epilepticus in adults: Management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/14103.html" rel="external">
          "Nonconvulsive status epilepticus: Classification, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p>
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          Propofol
         </a>
         has potent antiseizure effects but can cause dose-dependent hypotension, so the dose for RSI must be calculated carefully. The induction dose of propofol is 1 to 2.5 mg/kg and, because of the tendency to produce hypotension, the drug is usually pushed more slowly than other induction agents (over 30 to 45 seconds), making administration and RSI more complex.
        </p>
        <p>
         We prefer
         <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">
          etomidate
         </a>
         in the setting of persistent seizures related to acute neurologic trauma in patients at risk for hypotension, which would exacerbate secondary brain injury. Etomidate can cause myoclonus, and has a slightly higher rate of electroencephalogram (EEG)-documented seizure activity compared with other medications [
         <a href="#rid91">
          91-93
         </a>
         ]. However, it is short acting and may be used safely for RSI in status epilepticus [
         <a href="#rid94">
          94
         </a>
         ], then followed with a sedative with antiseizure effects, such as
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         or a benzodiazepine, to maintain sedation.
        </p>
        <p>
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          Midazolam
         </a>
         may be used for induction, but care must be taken to use doses appropriate for RSI (0.2 to 0.3 mg/kg intravenous [IV] bolus), account for its slower onset, and be wary of dose-dependent hypotension [
         <a href="#rid29">
          29,30
         </a>
         ]. Although evidence is lacking, we suggest
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          ketamine
         </a>
         <strong>
          not
         </strong>
         be used in this setting because of its stimulant effects.
        </p>
        <p>
         Following the administration of a sedative for RSI, appropriate antiseizure treatment should be started as soon as is feasible following successful intubation.
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h2">
          Reactive airway disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         For hemodynamically stable patients with severe bronchospasm requiring intubation, we suggest
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          ketamine
         </a>
         or
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         be used for induction, because of their bronchodilatory properties [
         <a href="#rid23">
          23,39
         </a>
         ].
         <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">
          Etomidate
         </a>
         is an acceptable alternative. In hypotensive patients, we prefer ketamine or etomidate. None of these agents causes histamine release. (See
         <a class="medical medical_review" href="/z/d/html/528.html" rel="external">
          "Acute exacerbations of asthma in adults: Home and office management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h2">
          Cardiovascular disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         We suggest
         <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">
          etomidate
         </a>
         for induction of the patient with significant cardiovascular disease requiring RSI [
         <a href="#rid17">
          17,18,20,95
         </a>
         ]. The hemodynamic stability it provides and the absence of induced hypertension make it preferable to other sedatives. (See
         <a class="local">
          'Etomidate'
         </a>
         above.)
        </p>
        <p>
         In patients with coronary artery disease or suspected aortic dissection, we suggest giving
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         (3 mcg/kg) as a pretreatment agent to mitigate the catecholamine release associated with laryngoscopy and intubation. Pretreatment is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/282.html" rel="external">
          "Pretreatment medications for rapid sequence intubation in adults for emergency medicine and critical care", section on 'Choice of pretreatment agents'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h2">
          Shock
         </span>
         <span class="headingEndMark">
          —
         </span>
         All sedative agents can cause hypotension when administered to patients who are hemodynamically unstable [
         <a href="#rid70">
          70,94,96,97
         </a>
         ]. We suggest IV
         <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">
          etomidate
         </a>
         0.15 mg/kg [
         <a href="#rid96">
          96
         </a>
         ], or, alternatively, IV
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          ketamine
         </a>
         1 mg/kg for induction of the patient in shock requiring RSI. (See
         <a class="local">
          'Etomidate'
         </a>
         above and
         <a class="local">
          'Ketamine'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/270.html" rel="external">
          "Rapid sequence intubation in adults for emergency medicine and critical care"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/98976.html" rel="external">
          "Evaluation of and initial approach to the adult patient with undifferentiated hypotension and shock"
         </a>
         .)
        </p>
        <p>
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          Ketamine
         </a>
         causes a sympathetic surge that may augment endogenous catecholamines but may also elevate intracranial pressure.
         <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">
          Etomidate
         </a>
         has been scrutinized because of its transient suppression of endogenous cortisol, but this effect has not been found to be clinically relevant. Both agents cause a small drop in MAP in patients with severe hypotension, but less than other sedative agents. These issues are discussed in detail above. (See
         <a class="local">
          'Elevated intracranial pressure'
         </a>
         above and
         <a class="local">
          'Adrenocortical suppression'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h1">
          CONDITIONS PRECLUDING USE OF A PARALYTIC
         </span>
         <span class="headingEndMark">
          —
         </span>
         Conditions may exist that preclude the use of a paralytic for intubation (ie, precludes rapid sequence intubation [RSI]). The clinician may then decide to use an appropriate sedative or combination of sedatives and topical anesthesia to facilitate laryngoscopy and assess the airway, while allowing the patient to maintain his respiratory drive. This approach, referred to as a "sedated look" or "awake look," is used when the clinician suspects the airway will be difficult to intubate, and allows the practitioner to verify that laryngeal structures are visible, before committing to paralysis.
        </p>
        <p>
         The sedated look approach is distinct from the older practice of "intubation with sedation alone" or "non-paralytic RSI," in which the patient receives a full induction dose of a sedative agent, but no neuromuscular blocking agent. The older practice is to be avoided, as it creates a vulnerable, compromised patient in whom intubating conditions are far from ideal [
         <a href="#rid98">
          98,99
         </a>
         ]. In general, if the clinician anticipates a difficult intubation which may preclude successful RSI, an "awake look" or "sedated look" is advised. If the clinician does not anticipate a difficult airway, RSI with a full induction dose of a sedative agent, accompanied by a full dose of a paralytic agent, is advised.
        </p>
        <p>
         Multiple medications have been studied, primarily in the operating room, to determine which agents are appropriate for "sedated looks" [
         <a href="#rid1">
          1,100-107
         </a>
         ]. In general, the use of topical anesthesia (eg, nebulized 4 percent
         <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">
          lidocaine
         </a>
         ) along with moderate sedation allows for a look into the airway, while enabling the patient to maintain respiratory drive and protective airway reflexes.
        </p>
        <p>
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          Ketamine
         </a>
         is gaining popularity in this circumstance because it allows the patient to maintain respiratory drive while providing analgesia, amnesia, and sedation [
         <a href="#rid36">
          36,49,101,108
         </a>
         ]. Ketamine's analgesic properties allow it to be used as the sole agent in the bloody traumatized airway, when topical anesthesia is unlikely to work effectively. More research is needed to determine which sedatives are best for "sedated looks" in the emergency setting.
        </p>
        <p class="headingAnchor" id="H897943273">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/127884.html" rel="external">
          "Society guideline links: Airway management in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H21">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Rapid sequence intubation
         </strong>
         – Rapid sequence intubation (RSI) is the standard of care in emergency airway management for intubations not anticipated to be difficult. RSI involves combining a sedative and a paralytic agent to render a patient rapidly unconscious and flaccid in order to facilitate emergency tracheal intubation and to minimize the risk of aspiration. (See
         <a class="medical medical_review" href="/z/d/html/270.html" rel="external">
          "Rapid sequence intubation in adults for emergency medicine and critical care"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6390.html" rel="external">
          "Rapid sequence intubation (RSI) in children for emergency medicine: Approach"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preferred induction agents by clinical scenario
         </strong>
         – Different clinical scenarios lend themselves to the use of certain sedatives when RSI is needed (
         <a class="graphic graphic_table graphicRef64272" href="/z/d/graphic/64272.html" rel="external">
          table 1
         </a>
         ). We suggest the following induction agents be used in the specific clinical circumstances described below (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Head injury or elevated ICP
         </strong>
         – In the patient with a head injury or potentially elevated intracranial pressure (ICP), adequate cerebral perfusion pressure must be maintained to prevent secondary brain injury. We suggest
         <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">
          etomidate
         </a>
         or
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          ketamine
         </a>
         for induction of these patients during RSI. For hypotensive patients, etomidate or ketamine may be used. Ketamine should be avoided in patients with hypertension (MABP &gt;120 mmHg) or if signs of cerebral herniation are present. (See
         <a class="local">
          'Head injury or stroke'
         </a>
         above and
         <a class="local">
          'Etomidate'
         </a>
         above and
         <a class="local">
          'Ketamine'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Status epilepticus
         </strong>
         – We suggest
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         or
         <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">
          etomidate
         </a>
         be used for induction of RSI. Etomidate may be used when the patient manifests hemodynamic compromise. We suggest
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          ketamine
         </a>
         <strong>
          not
         </strong>
         be used because of its stimulant effects.
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          Midazolam
         </a>
         is an acceptable alternative, but care must be taken to administer an appropriate induction dose (0.1 to 0.3 mg/kg) and to guard against dose-dependent hypotension. (See
         <a class="local">
          'Status epilepticus'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Severe bronchospasm
         </strong>
         – For the
         <strong>
          hemodynamically stable
         </strong>
         patient with severe bronchospasm requiring intubation, we suggest induction with
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          ketamine
         </a>
         or
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         .
         <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">
          Etomidate
         </a>
         or
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          midazolam
         </a>
         is an acceptable alternative. In
         <strong>
          hemodynamically unstable
         </strong>
         patients with severe bronchospasm, we suggest ketamine or etomidate. (See
         <a class="local">
          'Reactive airway disease'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Cardiovascular compromise
         </strong>
         – For induction of the patient with cardiovascular compromise requiring RSI, we suggest
         <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">
          etomidate
         </a>
         because of the hemodynamic stability it provides. (See
         <a class="local">
          'Cardiovascular disease'
         </a>
         above and
         <a class="local">
          'Etomidate'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Shock
         </strong>
         – For induction of the patient in shock requiring RSI, we suggest low-dose intravenous (IV)
         <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">
          etomidate
         </a>
         (0.15 mg/kg) or, alternatively, IV
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          ketamine
         </a>
         (1 mg/kg). If etomidate is used in a patient with sepsis and hypotension refractory to treatment with fluid resuscitation and a vasopressor, we suggest that a single dose of glucocorticoid (eg,
         <a class="drug drug_general" data-topicid="8535" href="/z/d/drug information/8535.html" rel="external">
          hydrocortisone
         </a>
         100 mg IV) be given. (See
         <a class="local">
          'Shock'
         </a>
         above and
         <a class="local">
          'Etomidate'
         </a>
         above and
         <a class="local">
          'Ketamine'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          “Awake” intubation
         </strong>
         – For induction of most patients with conditions precluding the use of paralytics in whom an "awake look" is necessary for intubation, we suggest
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          ketamine
         </a>
         . Ketamine may not be appropriate when these patients have cardiovascular disease or hypertension. (See
         <a class="local">
          'Conditions precluding use of a paralytic'
         </a>
         above and
         <a class="local">
          'Ketamine'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Li J, Murphy-Lavoie H, Bugas C, et al. Complications of emergency intubation with and without paralysis. Am J Emerg Med 1999; 17:141.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sagarin MJ, Chiang V, Sakles JC, et al. Rapid sequence intubation for pediatric emergency airway management. Pediatr Emerg Care 2002; 18:417.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sakles JC, Laurin EG, Rantapaa AA, Panacek EA. Airway management in the emergency department: a one-year study of 610 tracheal intubations. Ann Emerg Med 1998; 31:325.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tayal VS, Riggs RW, Marx JA, et al. Rapid-sequence intubation at an emergency medicine residency: success rate and adverse events during a two-year period. Acad Emerg Med 1999; 6:31.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sivilotti ML, Filbin MR, Murray HE, et al. Does the sedative agent facilitate emergency rapid sequence intubation? Acad Emerg Med 2003; 10:612.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ballard N, Robley L, Barrett D, et al. Patients' recollections of therapeutic paralysis in the intensive care unit. Am J Crit Care 2006; 15:86.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Playfor SD, Thomas DA, Choonara I I. Recall following paediatric intensive care. Paediatr Anaesth 2000; 10:703.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Topulos GP, Lansing RW, Banzett RB. The experience of complete neuromuscular blockade in awake humans. J Clin Anesth 1993; 5:369.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wagner BK, Zavotsky KE, Sweeney JB, et al. Patient recall of therapeutic paralysis in a surgical critical care unit. Pharmacotherapy 1998; 18:358.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sivilotti ML, Ducharme J. Randomized, double-blind study on sedatives and hemodynamics during rapid-sequence intubation in the emergency department: The SHRED Study. Ann Emerg Med 1998; 31:313.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Denmark TK, Crane HA, Brown L. Ketamine to avoid mechanical ventilation in severe pediatric asthma. J Emerg Med 2006; 30:163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           El-Orbany MI, Wafai Y, Joseph NJ, Salem MR. Does the choice of intravenous induction drug affect intubation conditions after a fast-onset neuromuscular blocker? J Clin Anesth 2003; 15:9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Skinner HJ, Biswas A, Mahajan RP. Evaluation of intubating conditions with rocuronium and either propofol or etomidate for rapid sequence induction. Anaesthesia 1998; 53:702.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bergen JM, Smith DC. A review of etomidate for rapid sequence intubation in the emergency department. J Emerg Med 1997; 15:221.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Benson M, Junger A, Fuchs C, et al. Use of an anesthesia information management system (AIMS) to evaluate the physiologic effects of hypnotic agents used to induce anesthesia. J Clin Monit Comput 2000; 16:183.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fuchs-Buder T, Sparr HJ, Ziegenfuss T. Thiopental or etomidate for rapid sequence induction with rocuronium. Br J Anaesth 1998; 80:504.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guldner G, Schultz J, Sexton P, et al. Etomidate for rapid-sequence intubation in young children: hemodynamic effects and adverse events. Acad Emerg Med 2003; 10:134.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jellish WS, Riche H, Salord F, et al. Etomidate and thiopental-based anesthetic induction: comparisons between different titrated levels of electrophysiologic cortical depression and response to laryngoscopy. J Clin Anesth 1997; 9:36.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sokolove PE, Price DD, Okada P. The safety of etomidate for emergency rapid sequence intubation of pediatric patients. Pediatr Emerg Care 2000; 16:18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zed PJ, Abu-Laban RB, Harrison DW. Intubating conditions and hemodynamic effects of etomidate for rapid sequence intubation in the emergency department: an observational cohort study. Acad Emerg Med 2006; 13:378.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oglesby AJ. Should etomidate be the induction agent of choice for rapid sequence intubation in the emergency department? Emerg Med J 2004; 21:655.
          </a>
         </li>
         <li class="breakAll">
          Schneider, RE, Caro, DA. Pretreatment agents. In: Manual of Emergency Airway Management, Walls, RM (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2004. p.185.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eames WO, Rooke GA, Wu RS, Bishop MJ. Comparison of the effects of etomidate, propofol, and thiopental on respiratory resistance after tracheal intubation. Anesthesiology 1996; 84:1307.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kox WJ, von Heymann C, Heinze J, et al. Electroencephalographic mapping during routine clinical practice: cortical arousal during tracheal intubation? Anesth Analg 2006; 102:825.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reddy RV, Moorthy SS, Dierdorf SF, et al. Excitatory effects and electroencephalographic correlation of etomidate, thiopental, methohexital, and propofol. Anesth Analg 1993; 77:1008.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           den Brinker M, Joosten KF, Liem O, et al. Adrenal insufficiency in meningococcal sepsis: bioavailable cortisol levels and impact of interleukin-6 levels and intubation with etomidate on adrenal function and mortality. J Clin Endocrinol Metab 2005; 90:5110.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Payen JF, Dupuis C, Trouve-Buisson T, et al. Corticosteroid after etomidate in critically ill patients: a randomized controlled trial. Crit Care Med 2012; 40:29.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blumer JL. Clinical pharmacology of midazolam in infants and children. Clin Pharmacokinet 1998; 35:37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nordt SP, Clark RF. Midazolam: a review of therapeutic uses and toxicity. J Emerg Med 1997; 15:357.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sagarin MJ, Barton ED, Sakles JC, et al. Underdosing of midazolam in emergency endotracheal intubation. Acad Emerg Med 2003; 10:329.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Wildt SN, de Hoog M, Vinks AA, et al. Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients. Crit Care Med 2003; 31:1952.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tobias JD, Berkenbosch JW. Sedation during mechanical ventilation in infants and children: dexmedetomidine versus midazolam. South Med J 2004; 97:451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mulla H, McCormack P, Lawson G, et al. Pharmacokinetics of midazolam in neonates undergoing extracorporeal membrane oxygenation. Anesthesiology 2003; 99:275.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilson KC, Reardon C, Theodore AC, Farber HW. Propylene glycol toxicity: a severe iatrogenic illness in ICU patients receiving IV benzodiazepines: a case series and prospective, observational pilot study. Chest 2005; 128:1674.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Långsjö JW, Kaisti KK, Aalto S, et al. Effects of subanesthetic doses of ketamine on regional cerebral blood flow, oxygen consumption, and blood volume in humans. Anesthesiology 2003; 99:614.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rogers R, Wise RG, Painter DJ, et al. An investigation to dissociate the analgesic and anesthetic properties of ketamine using functional magnetic resonance imaging. Anesthesiology 2004; 100:292.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hanouz JL, Persehaye E, Zhu L, et al. The inotropic and lusitropic effects of ketamine in isolated human atrial myocardium: the effect of adrenoceptor blockade. Anesth Analg 2004; 99:1689.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hanouz JL, Zhu L, Persehaye E, et al. Ketamine preconditions isolated human right atrial myocardium: roles of adenosine triphosphate-sensitive potassium channels and adrenoceptors. Anesthesiology 2005; 102:1190.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allen JY, Macias CG. The efficacy of ketamine in pediatric emergency department patients who present with acute severe asthma. Ann Emerg Med 2005; 46:43.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen RM, Chen TL, Lin YL, et al. Ketamine reduces nitric oxide biosynthesis in human umbilical vein endothelial cells by down-regulating endothelial nitric oxide synthase expression and intracellular calcium levels. Crit Care Med 2005; 33:1044.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ho KK, Flood P. Single amino acid residue in the extracellular portion of transmembrane segment 2 in the nicotinic alpha7 acetylcholine receptor modulates sensitivity to ketamine. Anesthesiology 2004; 100:657.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller M, Kruit N, Heldreich C, et al. Hemodynamic Response After Rapid Sequence Induction With Ketamine in Out-of-Hospital Patients at Risk of Shock as Defined by the Shock Index. Ann Emerg Med 2016; 68:181.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           April MD, Arana A, Schauer SG, et al. Ketamine Versus Etomidate and Peri-intubation Hypotension: A National Emergency Airway Registry Study. Acad Emerg Med 2020; 27:1106.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mohr NM, Pape SG, Runde D, et al. Etomidate Use Is Associated With Less Hypotension Than Ketamine for Emergency Department Sepsis Intubations: A NEAR Cohort Study. Acad Emerg Med 2020; 27:1140.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grace RF. The effect of variable-dose diazepam on dreaming and emergence phenomena in 400 cases of ketamine-fentanyl anaesthesia. Anaesthesia 2003; 58:904.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cornelius BG, Webb E, Cornelius A, et al. Effect of sedative agent selection on morbidity, mortality and length of stay in patients with increase in intracranial pressure. World J Emerg Med 2018; 9:256.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wyte SR, Shapiro HM, Turner P, Harris AB. Ketamine-induced intracranial hypertension. Anesthesiology 1972; 36:174.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gardner AE, Dannemiller FJ, Dean D. Intracranial cerebrospinal fluid pressure in man during ketamine anesthesia. Anesth Analg 1972; 51:741.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Himmelseher S, Durieux ME. Revising a dogma: ketamine for patients with neurological injury? Anesth Analg 2005; 101:524.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Albanèse J, Arnaud S, Rey M, et al. Ketamine decreases intracranial pressure and electroencephalographic activity in traumatic brain injury patients during propofol sedation. Anesthesiology 1997; 87:1328.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bucher J, Koyfman A. Intubation of the Neurologically Injured Patient. J Emerg Med 2015; 49:920.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Green SM, Andolfatto G, Krauss BS. Ketamine and intracranial pressure: no contraindication except hydrocephalus. Ann Emerg Med 2015; 65:52.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hughes S. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 3: is ketamine a viable induction agent for the trauma patient with potential brain injury. Emerg Med J 2011; 28:1076.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen L, Athaide V, Wickham ME, et al. The effect of ketamine on intracranial and cerebral perfusion pressure and health outcomes: a systematic review. Ann Emerg Med 2015; 65:43.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Långsjö JW, Salmi E, Kaisti KK, et al. Effects of subanesthetic ketamine on regional cerebral glucose metabolism in humans. Anesthesiology 2004; 100:1065.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hudetz JA, Pagel PS. Neuroprotection by ketamine: a review of the experimental and clinical evidence. J Cardiothorac Vasc Anesth 2010; 24:131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bourgoin A, Albanèse J, Léone M, et al. Effects of sufentanil or ketamine administered in target-controlled infusion on the cerebral hemodynamics of severely brain-injured patients. Crit Care Med 2005; 33:1109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Veselis RA, Reinsel RA, Feshchenko VA, Johnson R Jr. Information loss over time defines the memory defect of propofol: a comparative response with thiopental and dexmedetomidine. Anesthesiology 2004; 101:831.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Veselis RA, Feshchenko VA, Reinsel RA, et al. Propofol and thiopental do not interfere with regional cerebral blood flow response at sedative concentrations. Anesthesiology 2005; 102:26.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kodaka M, Johansen JW, Sebel PS. The influence of gender on loss of consciousness with sevoflurane or propofol. Anesth Analg 2005; 101:377.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shangguan WN, Lian Q, Aarons L, et al. Pharmacokinetics of a single bolus of propofol in chinese children of different ages. Anesthesiology 2006; 104:27.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Muñoz HR, Cortínez LI, Ibacache ME, Altermatt FR. Estimation of the plasma effect site equilibration rate constant (ke0) of propofol in children using the time to peak effect: comparison with adults. Anesthesiology 2004; 101:1269.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Conti G, Ferretti A, Tellan G, et al. Propofol induces bronchodilation in a patient mechanically ventilated for status asthmaticus. Intensive Care Med 1993; 19:305.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pizov R, Brown RH, Weiss YS, et al. Wheezing during induction of general anesthesia in patients with and without asthma. A randomized, blinded trial. Anesthesiology 1995; 82:1111.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bein B, Renner J, Caliebe D, et al. Sevoflurane but not propofol preserves myocardial function during minimally invasive direct coronary artery bypass surgery. Anesth Analg 2005; 100:610.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ebert TJ. Sympathetic and hemodynamic effects of moderate and deep sedation with propofol in humans. Anesthesiology 2005; 103:20.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Masuda T, Tomiyama Y, Kitahata H, et al. Propofol inhibits volume-sensitive chloride channels in human coronary artery smooth muscle cells. Anesth Analg 2003; 97:657.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Win NN, Fukayama H, Kohase H, Umino M. The different effects of intravenous propofol and midazolam sedation on hemodynamic and heart rate variability. Anesth Analg 2005; 101:97.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steiner LA, Johnston AJ, Chatfield DA, et al. The effects of large-dose propofol on cerebrovascular pressure autoregulation in head-injured patients. Anesth Analg 2003; 97:572.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aitkenhead AR, Pepperman ML, Willatts SM, et al. Comparison of propofol and midazolam for sedation in critically ill patients. Lancet 1989; 2:704.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Whyte SD, Booker PD, Buckley DG. The effects of propofol and sevoflurane on the QT interval and transmural dispersion of repolarization in children. Anesth Analg 2005; 100:71.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paventi S, Santevecchi A, Ranieri R. Effects of sevoflurane versus propofol on QT interval. Minerva Anestesiol 2001; 67:637.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gottschling S, Meyer S, Krenn T, et al. Effects of short-term propofol administration on pancreatic enzymes and triglyceride levels in children. Anaesthesia 2005; 60:660.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gallo de Moraes A, Racedo Africano CJ, Hoskote SS, et al. Ketamine and propofol combination ("ketofol") for endotracheal intubations in critically ill patients: a case series. Am J Case Rep 2015; 16:81.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hosseinzadeh H, Eidy M, Golzari SE, Vasebi M. Hemodynamic Stability during Induction of Anesthesia in ElderlyPatients: Propofol + Ketamine versus Propofol + Etomidate. J Cardiovasc Thorac Res 2013; 5:51.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smischney NJ, Beach ML, Loftus RW, et al. Ketamine/propofol admixture (ketofol) is associated with improved hemodynamics as an induction agent: a randomized, controlled trial. J Trauma Acute Care Surg 2012; 73:94.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gholipour Baradari A, Firouzian A, Zamani Kiasari A, et al. Effect of Etomidate Versus Combination of Propofol-Ketamine and Thiopental-Ketamine on Hemodynamic Response to Laryngoscopy and Intubation: A Randomized Double Blind Clinical Trial. Anesth Pain Med 2016; 6:e30071.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meço BC, Bermede AO, Alanoğlu Z, et al. Influence of Different Doses of Ketamine on Intubating Conditions during a Rapid Sequence Induction and Intubation Model. Turk J Anaesthesiol Reanim 2016; 44:26.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Russo H, Bressolle F. Pharmacodynamics and pharmacokinetics of thiopental. Clin Pharmacokinet 1998; 35:95.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reich DL, Hossain S, Krol M, et al. Predictors of hypotension after induction of general anesthesia. Anesth Analg 2005; 101:622.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hirota K, Ohtomo N, Hashimoto Y, et al. Effects of thiopental on airway calibre in dogs: direct visualization method using a superfine fibreoptic bronchoscope. Br J Anaesth 1998; 81:203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Keel M, Mica L, Stover J, et al. Thiopental-induced apoptosis in lymphocytes is independent of CD95 activation. Anesthesiology 2005; 103:576.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ploppa A, Kiefer RT, Nohé B, et al. Dose-dependent influence of barbiturates but not of propofol on human leukocyte phagocytosis of viable Staphylococcus aureus. Crit Care Med 2006; 34:478.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sato M, Tanaka S, Suzuki K, et al. Complications associated with barbiturate therapy. Resuscitation 1989; 17:233.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schalén W, Messeter K, Nordström CH. Complications and side effects during thiopentone therapy in patients with severe head injuries. Acta Anaesthesiol Scand 1992; 36:369.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stover JF, Stocker R. Barbiturate coma may promote reversible bone marrow suppression in patients with severe isolated traumatic brain injury. Eur J Clin Pharmacol 1998; 54:529.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Loop T, Humar M, Pischke S, et al. Thiopental inhibits tumor necrosis factor alpha-induced activation of nuclear factor kappaB through suppression of kappaB kinase activity. Anesthesiology 2003; 99:360.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marvez-Valls E, Houry D, Ernst AA, et al. Protocol for rapid sequence intubation in pediatric patients -- a four-year study. Med Sci Monit 2002; 8:CR229.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sonday CJ, Axelband J, Jacoby J, et al. Thiopental vs. etomidate for rapid sequence intubation in aeromedicine. Prehosp Disaster Med 2005; 20:324.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Choi YF, Wong TW, Lau CC. Midazolam is more likely to cause hypotension than etomidate in emergency department rapid sequence intubation. Emerg Med J 2004; 21:700.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jackson WL Jr. Should we use etomidate as an induction agent for endotracheal intubation in patients with septic shock?: a critical appraisal. Chest 2005; 127:1031.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Singh PM, Arora S, Borle A, et al. Evaluation of Etomidate for Seizure Duration in Electroconvulsive Therapy: A Systematic Review and Meta-analysis. J ECT 2015; 31:213.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rampp S, Schmitt HJ, Heers M, et al. Etomidate activates epileptic high frequency oscillations. Clin Neurophysiol 2014; 125:223.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Perier F, Chateauneuf AL, Jacq G, et al. Comparison of etomidate and sodium thiopental for induction during rapid sequence intubation in convulsive status epilepticus: A retrospective single-center study. Seizure 2018; 61:170.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sarkar M, Laussen PC, Zurakowski D, et al. Hemodynamic responses to etomidate on induction of anesthesia in pediatric patients. Anesth Analg 2005; 101:645.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim JM, Shin TG, Hwang SY, et al. Sedative dose and patient variable impacts on postintubation hypotension in emergency airway management. Am J Emerg Med 2019; 37:1248.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zuin M, Rigatelli G, Dell'Avvocata F, et al. Ketamine and midazolam differently impact post-intubation hemodynamic profile when used as induction agents during emergency airway management in hemodynamically stable patients with ST elevation myocardial infarction. Heart Vessels 2018; 33:213.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kirkegaard-Nielsen H, Caldwell JE, Berry PD. Rapid tracheal intubation with rocuronium: a probability approach to determining dose. Anesthesiology 1999; 91:131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Naguib M, Samarkandi A, Riad W, Alharby SW. Optimal dose of succinylcholine revisited. Anesthesiology 2003; 99:1045.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Durmus M, Ender G, Kadir BA, et al. Remifentanil with thiopental for tracheal intubation without muscle relaxants. Anesth Analg 2003; 96:1336.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bahk JH, Sung J, Jang IJ. A comparison of ketamine and lidocaine spray with propofol for the insertion of laryngeal mask airway in children: a double-blinded randomized trial. Anesth Analg 2002; 95:1586.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bair AE, Filbin MR, Kulkarni RG, Walls RM. The failed intubation attempt in the emergency department: analysis of prevalence, rescue techniques, and personnel. J Emerg Med 2002; 23:131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bozeman WP, Young S. Etomidate as a sole agent for endotracheal intubation in the prehospital air medical setting. Air Med J 2002; 21:32.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De Fátima De Assunção Braga A, Da Silva Braga FS, Potério GM, et al. The effect of different doses of propofol on tracheal intubating conditions without muscle relaxant in children. Eur J Anaesthesiol 2001; 18:384.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Erhan E, Ugur G, Alper I, et al. Tracheal intubation without muscle relaxants: remifentanil or alfentanil in combination with propofol. Eur J Anaesthesiol 2003; 20:37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liou CM, Hung WT, Chen CC, et al. Improving the success rate of laryngeal mask airway insertion during etomidate induction by using fentanyl or succinylcholine. Acta Anaesthesiol Taiwan 2004; 42:209.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taha S, Siddik-Sayyid S, Alameddine M, et al. Propofol is superior to thiopental for intubation without muscle relaxants. Can J Anaesth 2005; 52:249.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berkenbosch JW, Graff GR, Stark JM. Safety and efficacy of ketamine sedation for infant flexible fiberoptic bronchoscopy. Chest 2004; 125:1132.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 271 Version 35.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10102312" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Complications of emergency intubation with and without paralysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12488834" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Rapid sequence intubation for pediatric emergency airway management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9506489" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Airway management in the emergency department: a one-year study of 610 tracheal intubations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9928974" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Rapid-sequence intubation at an emergency medicine residency: success rate and adverse events during a two-year period.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12782521" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Does the sedative agent facilitate emergency rapid sequence intubation?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16391318" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Patients' recollections of therapeutic paralysis in the intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11119241" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Recall following paediatric intensive care
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8105828" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : The experience of complete neuromuscular blockade in awake humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9545155" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Patient recall of therapeutic paralysis in a surgical critical care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9506488" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Randomized, double-blind study on sedatives and hemodynamics during rapid-sequence intubation in the emergency department: The SHRED Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16567251" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Ketamine to avoid mechanical ventilation in severe pediatric asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12657404" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Does the choice of intravenous induction drug affect intubation conditions after a fast-onset neuromuscular blocker?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9771181" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Evaluation of intubating conditions with rocuronium and either propofol or etomidate for rapid sequence induction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9144065" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : A review of etomidate for rapid sequence intubation in the emergency department.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12578102" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Use of an anesthesia information management system (AIMS) to evaluate the physiologic effects of hypnotic agents used to induce anesthesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9640158" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Thiopental or etomidate for rapid sequence induction with rocuronium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12574010" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Etomidate for rapid-sequence intubation in young children: hemodynamic effects and adverse events.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9051544" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Etomidate and thiopental-based anesthetic induction: comparisons between different titrated levels of electrophysiologic cortical depression and response to laryngoscopy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10698137" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : The safety of etomidate for emergency rapid sequence intubation of pediatric patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16531603" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Intubating conditions and hemodynamic effects of etomidate for rapid sequence intubation in the emergency department: an observational cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15496686" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Should etomidate be the induction agent of choice for rapid sequence intubation in the emergency department?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15496686" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Should etomidate be the induction agent of choice for rapid sequence intubation in the emergency department?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8669670" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Comparison of the effects of etomidate, propofol, and thiopental on respiratory resistance after tracheal intubation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16492836" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Electroencephalographic mapping during routine clinical practice: cortical arousal during tracheal intubation?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8214699" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Excitatory effects and electroencephalographic correlation of etomidate, thiopental, methohexital, and propofol.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15985474" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Adrenal insufficiency in meningococcal sepsis: bioavailable cortisol levels and impact of interleukin-6 levels and intubation with etomidate on adrenal function and mortality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21926601" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Corticosteroid after etomidate in critically ill patients: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9673833" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Clinical pharmacology of midazolam in infants and children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9258787" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Midazolam: a review of therapeutic uses and toxicity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12670846" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Underdosing of midazolam in emergency endotracheal intubation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12847388" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15180019" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Sedation during mechanical ventilation in infants and children: dexmedetomidine versus midazolam.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12883399" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Pharmacokinetics of midazolam in neonates undergoing extracorporeal membrane oxygenation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16162774" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Propylene glycol toxicity: a severe iatrogenic illness in ICU patients receiving IV benzodiazepines: a case series and prospective, observational pilot study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12960545" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Effects of subanesthetic doses of ketamine on regional cerebral blood flow, oxygen consumption, and blood volume in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14739803" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : An investigation to dissociate the analgesic and anesthetic properties of ketamine using functional magnetic resonance imaging.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15562055" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : The inotropic and lusitropic effects of ketamine in isolated human atrial myocardium: the effect of adrenoceptor blockade.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15915032" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Ketamine preconditions isolated human right atrial myocardium: roles of adenosine triphosphate-sensitive potassium channels and adrenoceptors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15988425" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : The efficacy of ketamine in pediatric emergency department patients who present with acute severe asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15891334" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Ketamine reduces nitric oxide biosynthesis in human umbilical vein endothelial cells by down-regulating endothelial nitric oxide synthase expression and intracellular calcium levels.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15108982" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Single amino acid residue in the extracellular portion of transmembrane segment 2 in the nicotinic alpha7 acetylcholine receptor modulates sensitivity to ketamine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27130803" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Hemodynamic Response After Rapid Sequence Induction With Ketamine in Out-of-Hospital Patients at Risk of Shock as Defined by the Shock Index.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32592205" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Ketamine Versus Etomidate and Peri-intubation Hypotension: A National Emergency Airway Registry Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32602974" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Etomidate Use Is Associated With Less Hypotension Than Ketamine for Emergency Department Sepsis Intubations: A NEAR Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12911367" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : The effect of variable-dose diazepam on dreaming and emergence phenomena in 400 cases of ketamine-fentanyl anaesthesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30181792" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Effect of sedative agent selection on morbidity, mortality and length of stay in patients with increase in intracranial pressure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Ketamine-induced intracranial hypertension.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Intracranial cerebrospinal fluid pressure in man during ketamine anesthesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16037171" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Revising a dogma: ketamine for patients with neurological injury?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9416717" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Ketamine decreases intracranial pressure and electroencephalographic activity in traumatic brain injury patients during propofol sedation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26416129" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Intubation of the Neurologically Injured Patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25245275" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Ketamine and intracranial pressure: no contraindication except hydrocephalus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22101599" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 3: is ketamine a viable induction agent for the trauma patient with potential brain injury.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25064742" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : The effect of ketamine on intracranial and cerebral perfusion pressure and health outcomes: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15114201" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Effects of subanesthetic ketamine on regional cerebral glucose metabolism in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19640746" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Neuroprotection by ketamine: a review of the experimental and clinical evidence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15891344" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Effects of sufentanil or ketamine administered in target-controlled infusion on the cerebral hemodynamics of severely brain-injured patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15448514" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Information loss over time defines the memory defect of propofol: a comparative response with thiopental and dexmedetomidine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15618783" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Propofol and thiopental do not interfere with regional cerebral blood flow response at sedative concentrations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16037147" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : The influence of gender on loss of consciousness with sevoflurane or propofol.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16394686" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Pharmacokinetics of a single bolus of propofol in chinese children of different ages.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15564932" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Estimation of the plasma effect site equilibration rate constant (ke0) of propofol in children using the time to peak effect: comparison with adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8408944" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Propofol induces bronchodilation in a patient mechanically ventilated for status asthmaticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7741285" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Wheezing during induction of general anesthesia in patients with and without asthma. A randomized, blinded trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15728039" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Sevoflurane but not propofol preserves myocardial function during minimally invasive direct coronary artery bypass surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15983452" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Sympathetic and hemodynamic effects of moderate and deep sedation with propofol in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12933379" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Propofol inhibits volume-sensitive chloride channels in human coronary artery smooth muscle cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15976213" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : The different effects of intravenous propofol and midazolam sedation on hemodynamic and heart rate variability.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12873955" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : The effects of large-dose propofol on cerebrovascular pressure autoregulation in head-injured patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2570958" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Comparison of propofol and midazolam for sedation in critically ill patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15616054" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : The effects of propofol and sevoflurane on the QT interval and transmural dispersion of repolarization in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11731753" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Effects of sevoflurane versus propofol on QT interval.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15960715" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Effects of short-term propofol administration on pancreatic enzymes and triglyceride levels in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25676819" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Ketamine and propofol combination ("ketofol") for endotracheal intubations in critically ill patients: a case series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24251011" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Hemodynamic Stability during Induction of Anesthesia in ElderlyPatients: Propofol + Ketamine versus Propofol + Etomidate.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22743378" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Ketamine/propofol admixture (ketofol) is associated with improved hemodynamics as an induction agent: a randomized, controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27110526" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Effect of Etomidate Versus Combination of Propofol-Ketamine and Thiopental-Ketamine on Hemodynamic Response to Laryngoscopy and Intubation: A Randomized Double Blind Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27366551" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Influence of Different Doses of Ketamine on Intubating Conditions during a Rapid Sequence Induction and Intubation Model.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9739479" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Pharmacodynamics and pharmacokinetics of thiopental.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16115962" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Predictors of hypotension after induction of general anesthesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9813524" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Effects of thiopental on airway calibre in dogs: direct visualization method using a superfine fibreoptic bronchoscope.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16129983" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Thiopental-induced apoptosis in lymphocytes is independent of CD95 activation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16424731" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Dose-dependent influence of barbiturates but not of propofol on human leukocyte phagocytosis of viable Staphylococcus aureus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2548269" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Complications associated with barbiturate therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1595344" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Complications and side effects during thiopentone therapy in patients with severe head injuries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9832294" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Barbiturate coma may promote reversible bone marrow suppression in patients with severe isolated traumatic brain injury.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12883408" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Thiopental inhibits tumor necrosis factor alpha-induced activation of nuclear factor kappaB through suppression of kappaB kinase activity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11951062" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Protocol for rapid sequence intubation in pediatric patients -- a four-year study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16295169" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Thiopental vs. etomidate for rapid sequence intubation in aeromedicine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15496697" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Midazolam is more likely to cause hypotension than etomidate in emergency department rapid sequence intubation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15764790" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Should we use etomidate as an induction agent for endotracheal intubation in patients with septic shock?: a critical appraisal.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25634566" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Evaluation of Etomidate for Seizure Duration in Electroconvulsive Therapy: A Systematic Review and Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23911722" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Etomidate activates epileptic high frequency oscillations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30176574" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Comparison of etomidate and sodium thiopental for induction during rapid sequence intubation in convulsive status epilepticus: A retrospective single-center study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16115968" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Hemodynamic responses to etomidate on induction of anesthesia in pediatric patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30220641" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Sedative dose and patient variable impacts on postintubation hypotension in emergency airway management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28889210" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Ketamine and midazolam differently impact post-intubation hemodynamic profile when used as induction agents during emergency airway management in hemodynamically stable patients with ST elevation myocardial infarction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10422938" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Rapid tracheal intubation with rocuronium: a probability approach to determining dose.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14576536" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Optimal dose of succinylcholine revisited.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12707129" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Remifentanil with thiopental for tracheal intubation without muscle relaxants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12456421" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : A comparison of ketamine and lidocaine spray with propofol for the insertion of laryngeal mask airway in children: a double-blinded randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12359280" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : The failed intubation attempt in the emergency department: analysis of prevalence, rescue techniques, and personnel.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12087322" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Etomidate as a sole agent for endotracheal intubation in the prehospital air medical setting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11412291" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : The effect of different doses of propofol on tracheal intubating conditions without muscle relaxant in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12557834" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Tracheal intubation without muscle relaxants: remifentanil or alfentanil in combination with propofol.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15679130" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Improving the success rate of laryngeal mask airway insertion during etomidate induction by using fentanyl or succinylcholine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15753494" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Propofol is superior to thiopental for intubation without muscle relaxants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15006978" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Safety and efficacy of ketamine sedation for infant flexible fiberoptic bronchoscopy.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
